← Open Payments lookup

PRASHANT GAJWANI: Open Payments

NPI 1770509283 · MISSOURI CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$113,825 in 205 payments from 13 companies in 2025. Trend: 2023 $64,093 · 2024 $104,296 · 2025 $113,825

Honoraria: $69,829Speaker / faculty: $31,805Travel & lodging: $7,972Food & beverage: $4,209Education: $10
CompanyPaymentsAmount
Axsome Therapeutics, Inc.80$74,708
Janssen Pharmaceuticals, Inc50$37,534
ABBVIE INC.19$365
Neurocrine BioSciences, Inc.8$232
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$212
E.R. Squibb & Sons, L.L.C.6$169
Otsuka America Pharmaceutical, Inc.8$160
Takeda Pharmaceuticals U.S.A., Inc.7$145
Corium, LLC9$137
Alkermes, Inc.3$72

Products named: Auvelity, SPRAVATO, VRAYLAR, INGREZZA, CAPLYTA, COBENFY, REXULTI, TRINTELLIX.

Industry payments across TX — which companies pay providers there.